May 19, 2009
(CIDRAP News) – President Barack Obama's appointment of New York City Health Commissioner Thomas Frieden, MD, MPH, to lead the Centers for Disease Control and Prevention (CDC) drew enthusiastic applause today from public health organizations and disease experts.
(CIDRAP News) The World Health Organization (WHO) plans to release clinical guidance that will say most patients sick with the novel H1N1 influenza (swine flu) will not need antiviral treatment, but the drugs should be considered for high-risk groups, a WHO official said today.
(CIDRAP News) – A new survey from Harvard University suggests that a majority of Americans are following the news about the novel H1N1 influenza (swine flu) and taking steps to avoid it, but they are not especially worried about catching it.
(CIDRAP News) – With the global outbreak of novel H1N1 influenza (swine flu) entering its fourth week, physicians at emergency rooms, clinics, and hospitals around the United States say they are overwhelmed with "worried well" who have as much as doubled their patient loads.
(CIDRAP News) – As state public health laboratories tackle their novel H1N1 influenza (swine flu) testing backlogs, the Centers for Disease Control and Prevention (CDC) said yesterday it expects to see rising case numbers across the nation along with cutbacks in the number of samples tested by states.
(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) today revised its novel H1N1 influenza (swine flu) guidance for schools, urging schools and parents to identify and isolate sick children rather than close schools when cases are identified or suspected.
(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) signaled today that it will change its current recommendation—which is to close schools for at least 2 weeks when a confirmed case of novel H1N1 swine flu is found among students—as health officials in the Seattle area and Minnesota scaled back their guidance to reflect more of a seasonal influenza approach.
(CIDRAP News) National and international health authorities said today that they have begun the first steps in manufacturing a vaccine against the novel H1N1 swine influenza, though they appeared to disagree over whether full-scale manufacturing will move forward.
